BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 8723485)

  • 1. Antiviral Chemotherapy in Avian Medicine-A Review.
    Szotowska I; Ledwoń A
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical and In Silico Studies of the Interaction between the Anti-Viral Agents Acyclovir and Penciclovir, and Human Serum Albumin.
    Abdelhameed AS; Bakheit AH; Almutairi FM; AlRabiah H; Kadi AA
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29113080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Fluoro-1-[(4S,5R)-5-(2-hydroxy-ethyl)-2,2-dimethyl-1,3-dioxolan-4-yl]pyrimidine-2,4(1H,3H)-dione.
    Mendoza A; Sosa-Rivadeneyra M; Sartillo-Piscil F; Quintero L; Flores-Alamo M
    Acta Crystallogr Sect E Struct Rep Online; 2010 May; 66(Pt 6):o1317. PubMed ID: 21579410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experiment on standardized cell culture assay in assessing the activities of Composite Artemisia Capillaris Tablets against hepatitis B virus replication in vitro.
    Han J; Zhao YL; Shan LM; Huang FJ; Xiao XH
    Chin J Integr Med; 2005 Mar; 11(1):54-6. PubMed ID: 15975310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus.
    Delaney WE; Edwards R; Colledge D; Shaw T; Torresi J; Miller TG; Isom HC; Bock CT; Manns MP; Trautwein C; Locarnini S
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1705-13. PubMed ID: 11353615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus.
    Fu L; Cheng YC
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3402-7. PubMed ID: 11083647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy for hepatitis B virus: the path forward?
    Shaw T; Locarnini S
    Drugs; 2000 Sep; 60(3):517-31. PubMed ID: 11030464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic hepatitis B: new antiviral therapies.
    Yao F; Gish RG
    Curr Gastroenterol Rep; 1999; 1(1):20-6. PubMed ID: 10980922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamivudine. A review of its therapeutic potential in chronic hepatitis B.
    Jarvis B; Faulds D
    Drugs; 1999 Jul; 58(1):101-41. PubMed ID: 10439933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors.
    Ono-Nita SK; Kato N; Shiratori Y; Lan KH; Yoshida H; Carrilho FJ; Omata M
    J Clin Invest; 1999 Jun; 103(12):1635-40. PubMed ID: 10377169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection.
    Genovesi EV; Lamb L; Medina I; Taylor D; Seifer M; Innaimo S; Colonno RJ; Standring DN; Clark JM
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3209-17. PubMed ID: 9835516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir.
    Seifer M; Hamatake RK; Colonno RJ; Standring DN
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3200-8. PubMed ID: 9835515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial injury. Lessons from the fialuridine trial.
    Honkoop P; Scholte HR; de Man RA; Schalm SW
    Drug Saf; 1997 Jul; 17(1):1-7. PubMed ID: 9258627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication.
    Ladner SK; Otto MJ; Barker CS; Zaifert K; Wang GH; Guo JT; Seeger C; King RW
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1715-20. PubMed ID: 9257747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus.
    Innaimo SF; Seifer M; Bisacchi GS; Standring DN; Zahler R; Colonno RJ
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1444-8. PubMed ID: 9210663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells.
    Korba BE; Boyd MR
    Antimicrob Agents Chemother; 1996 May; 40(5):1282-4. PubMed ID: 8723485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir.
    Shaw T; Mok SS; Locarnini SA
    Hepatology; 1996 Nov; 24(5):996-1002. PubMed ID: 8903366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.
    Walters KA; Tipples GA; Allen MI; Condreay LD; Addison WR; Tyrrell L
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1936-42. PubMed ID: 12760870
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.